X·CON 2019 – Healthtech →
Managing Director, D.E. Shaw and Co., L.P.
CEO of Dynamis Corporation
Chair, Department of Chemical Physiology, The Scripps Research Institute; Co-director, Center for Physiological Proteomics, The Scripps Research Institute
Founder, Gilt Groupe
CEO and Founder, Techstars
VP of Research & Policy, Ewing Marion Kauffman Foundation
Head of global research and development at Life Technologies
Serial Entrepreneur and Investor
October 17, 2019 · Boston
October 22, 2019 · Boston
October 29, 2019 · San Francisco
Sponsored · Whitepaper
Implementing electronic solutions for risk mitigation
Remain compliant and ensure optimal productivity
Xconomy Insight · Webinar
Potential cures and treatments for diseases are on the horizon for a growing number of patients, thanks to recent breakthroughs in CRISPR gene-editing technologies and in cell and gene therapy.
Tax credits help tech innovators attract capital, fuel growth
Xconomy offers a number of ways to subscribe for free!
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit/Ann Arbor, San Francisco, New York, Raleigh-Durham, Boulder/Denver, Texas, Wisconsin, Indiana, and beyond.
© 2007-2019, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.
Website development support from Andrew Koyfman with design support from Rob Hunter.